Approval for the diasorin eti-ab-auk plus assay.  The device is indicated for: eti-ab-auk plus is an in vitro enzyme immunoassay (eia) intended for the qualitative detection of antibodies to hepatitis b surface antigen (anti-hbs) in human erum or plasma (edta, citrate or heparin).  The eti-ab-auk plus is intended for manual use only.  The detection of anti-hbs is indicative of laboratory diagnosis for seroconversion from hepatitis b virus (hbv) infection.  Anti-hbs is also used to assess laboratory diagnosis of past exposure to hepatitis b in potential hepatitis b vaccine recipients and to determine the presence os an immune response in vaccine recipients.  The anti-hbs assay's performance has not been established for the monitoring of hvb disease or therapy.